Gene therapy drug Zolgensma has become the world’s most expensive drug, with the one-time treatment priced at $ US2.1255 million ($ A3 million). Swiss drugmaker Novartis has won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants. Novartis executives defended the price, saying that… Read More »
Puma Biotech has only retained commercial rights to its cancer drug Nerlynx in the U.S. and Japan after a series of licensing deals. But even the remaining U.S. launch doesn’t seem to be going well. In the first quarter, Nerlynx ginned up sales of $ 45.6 million, Puma said Thursday. That’s way below analyst expectations of… Read More »
The first drug for women suffering postpartum depression received federal approval on Tuesday, a move likely to pave the way for a wave of treatments to address a debilitating condition that is the most common complication of pregnancy. The drug works very quickly, within 48 hours — a significant improvement over currently available antidepressants, which… Read More »
Researchers came up with an advanced device to deliver the drugMintMotion for Passionate Productions By Clare Wilson A radical new treatment for Parkinson’s disease involves pumping drugs directly into the brain, but results from the latest trial can’t tell us whether it actually helps improve the lives of people with the condition. Parkinson’s disease certainly… Read More »
Here was the challenge for bioengineers: Find a way to for patients to take drugs — like insulin or monoclonal antibodies used to treat cancers and other diseases — without injections. The medicines are made of molecules too big to be absorbed through the stomach or intestines; in any event, the drugs would be quickly… Read More »
WASHINGTON (Reuters) – U.S. Senator Bernie Sanders sent a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge $ 375,000 annually for a medication that for years has been available to patients for free. U.S. Senator Bernie Sanders speaks during a news conference on Yemen resolution on Capitol Hill in… Read More »
The State of Maryland is getting new software to collect information about controlled substances dispensed in the state to facilitate better data sharing. The RxGov prescription drug monitoring platform, from NIC, provides near real-time data that will integrate with the Chesapeake Regional Information System for our Patients (CRISP), the state health information exchange. Data also… Read More »